Obstetrics & Gynecology Doctors in Portsmouth, NH Accepting Medicare

13 Obstetrics & Gynecology doctors found. Showing 1 - 13

Deeptha N. Sastry, MD Obstetrics & Gynecology - Obstetrics Medicare: Accepting Medicare Assignments Practice Location: 155 Griffin Rd, Portsmouth, NH 03801 Phone: 603-431-6011    Fax: 603-431-6227

Dr. Kathleen Marie Toivanen, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 875 Greenland Rd, Orchard Park, Suite B11, Portsmouth, NH 03801 Phone: 603-436-2667    Fax: 603-436-2673

Jean C. Ryan, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 875 Greenland Rd, Building A-1, Portsmouth, NH 03801 Phone: 603-436-1128    Fax: 603-431-4537

Mark A Chag, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: Harbour Women's Health, 155 Griffin Road, Portsmouth, NH 03801 Phone: 603-431-6011    Fax: 603-431-6227

Dr. Emily Jerszyk Amarosa, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 155 Griffin Rd, Portsmouth, NH 03801 Phone: 603-431-6011    Fax: 603-431-6227

Wendy A. Mclaughlin, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 875 Greenland Rd, Building A-1, Portsmouth, NH 03801 Phone: 603-436-1128    Fax: 603-431-4537

Elizabeth Spellman, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 155 Griffin Rd, Portsmouth, NH 03801 Phone: 603-431-6011

Sonja N. Nelson, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 875 Greenland Rd, Buildling A-1, Portsmouth, NH 03801 Phone: 603-436-1128    Fax: 603-431-4537

Albert J Lantinen Jr., M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: Harbour Women's Health, 155 Griffin Street, Portsmouth, NH 03801 Phone: 603-431-6011    Fax: 603-431-6227

Mrs. Caroline N Scoones, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 155 Griffin Rd, Portsmouth, NH 03801 Phone: 603-431-6011    Fax: 603-431-6227

Dr. Elizabeth Harvey Trevino, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 155 Griffin Rd, Portsmouth, NH 03801 Phone: 603-431-6011

Heidi L Keup, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 155 Griffin Rd, Portsmouth, NH 03801 Phone: 603-431-6011    Fax: 603-431-6227

Saroj Andreena Fleming, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 155 Griffin Rd, Apt 404, Portsmouth, NH 03801 Phone: 603-431-6011    Fax: 603-431-6227

News Archive

Genetic source of muscular dystrophy blocked

Researchers at the University of Rochester Medical Center have found a way to block the genetic flaw at the heart of a common form of muscular dystrophy. The results of the study, which were published today in the journal Science, could pave the way for new therapies that essentially reverse the symptoms of the disease.

BIOTRONIK completes patient enrollment in IN-TIME clinical trial to treat HF

BIOTRONIK SE & Co. KG, a leading manufacturer of cardiac devices, announced today that the last chronic heart failure patient was enrolled in IN-TIME at the Schwabing Clinic in Munich, Germany, with principle investigator Professor Stefan Sack, MD.

Celldex Therapeutics commences screening in CDX-1307 Phase 2 study for bladder cancer

Celldex Therapeutics, Inc. today announced that the first patient has been screened in a randomized Phase 2 study of the Company's novel, first-in-class antibody-based vaccine candidate from its Precision Targeted Immunotherapy (PTI) platform. This study will evaluate the CDX-1307 regimen in both neoadjuvant and adjuvant settings in patients with newly diagnosed muscle-invasive bladder cancers that express hCG-beta.

IMUC's ICT-107 vaccine product candidate targets cancer stem cells

ImmunoCellular Therapeutics today announced the results of a study in which it was shown that certain specific antigens are highly expressed on cancer stem cells (CSCs). This suggests that IMUC's lead cancer vaccine product candidate ICT-107, which targets those antigens, may effectively target not only the cells that make up the bulk of certain cancerous tumors, but also the CSCs that are widely believed to give rise to them and cause their recurrence.

OPKO Health acquires NK-1 compounds from Schering

OPKO Health, Inc. today announced that it has completed the acquisition of rolapitant and a related compound from Schering Corporation, a subsidiary of Merck & Co., Inc. ("Schering").

Read more Medical News

› Verified 4 days ago